Association of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan

医学 血液透析 危险系数 动静脉瘘 透析 比例危险模型 队列 内科学 中心静脉导管 置信区间 队列研究 肾脏替代疗法 死亡率 外科 导管
作者
Minoru Murakami,Naohiko Fujii,Eiichiro Kanda,Kan Kikuchi,Atsushi Wada,Takayuki Hamano,Ikuto Masakane
出处
期刊:American Journal of Nephrology [Karger Publishers]
卷期号:54 (3-4): 83-94 被引量:10
标识
DOI:10.1159/000529991
摘要

Introduction: Vascular access usage varies widely across countries. Previous studies have evaluated the association of clinical outcomes with the three types of vascular access, namely, arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled and cuffed central venous catheter (TC-CVC). However, little is known regarding the association between arterial superficialization (AS) and the mortality of patients. Methods: A nationwide cohort study was conducted using data from the Japanese Society for Dialysis Therapy Renal Data Registry (2006–2007). We included patients aged ≥20 years undergoing hemodialysis with a dialysis vintage ≥6 months. The exposures of interest were the four types of vascular access: AVF, AVG, AS, and TC-CVC. Cox proportional hazard models were used to evaluate the associations of vascular access types with 1-year all-cause and cause-specific mortality. Results: A total of 183,490 maintenance hemodialysis patients were included: 90.7% with AVF, 6.9% with AVG, 2.0% with AS, and 0.4% with TC-CVC. During the 1-year follow-up period, 13,798 patients died. Compared to patients with AVF, those with AVG, AS, and TC-CVC had a significantly higher risk of all-cause mortality after adjustment for confounding factors: adjusted hazard ratios (95% confidence intervals) – 1.30 (1.20–1.41), 1.56 (1.39–1.76), and 2.15 (1.77–2.61), respectively. Similar results were obtained for infection-related and cardiovascular mortality. Conclusion: This nationwide cohort study conducted in Japan suggested that AVF usage may have the lowest risk of all-cause mortality. The study also suggested that the usage of AS may be associated with better survival rates compared to those of TC-CVC in patients who are not suitable for AVF or AVG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI5应助科研通管家采纳,获得10
1秒前
CodeCraft应助科研通管家采纳,获得10
1秒前
华仔应助科研通管家采纳,获得10
1秒前
上官若男应助科研通管家采纳,获得10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
che应助科研通管家采纳,获得10
1秒前
bkagyin应助科研通管家采纳,获得10
1秒前
小宋应助科研通管家采纳,获得10
1秒前
赘婿应助DAGeee采纳,获得10
1秒前
烟花应助科研通管家采纳,获得10
1秒前
酷波er应助科研通管家采纳,获得10
1秒前
科研通AI5应助科研通管家采纳,获得10
1秒前
彭于晏应助科研通管家采纳,获得10
2秒前
我是老大应助科研通管家采纳,获得10
2秒前
大模型应助科研通管家采纳,获得10
2秒前
天天快乐应助科研通管家采纳,获得10
2秒前
2秒前
香蕉觅云应助叶子采纳,获得10
2秒前
3秒前
3秒前
脑洞疼应助半岛铁盒采纳,获得10
4秒前
华仔应助niulity采纳,获得10
4秒前
5秒前
科研通AI5应助wjw采纳,获得10
5秒前
7秒前
陈昭琼发布了新的文献求助10
8秒前
acc发布了新的文献求助10
9秒前
zhang001应助mkljl采纳,获得10
12秒前
席江海发布了新的文献求助30
13秒前
ZJU完成签到,获得积分10
16秒前
17秒前
科研通AI5应助蒋小亮采纳,获得10
20秒前
拼搏的如霜关注了科研通微信公众号
20秒前
20秒前
CodeCraft应助是谁采纳,获得10
21秒前
123321发布了新的文献求助10
23秒前
23秒前
23秒前
浮沉发布了新的文献求助10
25秒前
仿生人完成签到,获得积分10
26秒前
高分求助中
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children 5th Edition 2000
IZELTABART TAPATANSINE 500
Where and how to use plate heat exchangers 500
Seven new species of the Palaearctic Lauxaniidae and Asteiidae (Diptera) 400
Armour of the english knight 1400-1450 300
Handbook of Laboratory Animal Science 300
Not Equal : Towards an International Law of Finance 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3711967
求助须知:如何正确求助?哪些是违规求助? 3260213
关于积分的说明 9913178
捐赠科研通 2973601
什么是DOI,文献DOI怎么找? 1630690
邀请新用户注册赠送积分活动 773542
科研通“疑难数据库(出版商)”最低求助积分说明 744295